Gleason SD - Search Results

1

Multiple dopamine receptors mediate the discriminative stimulus effects of dihydrexidine in rats.

Gleason SD, Yin T, Little SP, Delapp N, Witkin JM. Gleason SD, et al. Behav Pharmacol. 2011 Sep;22(5-6):531-9. doi: 10.1097/FBP.0b013e328349aace. Behav Pharmacol. 2011. PMID: 21836463

2

Effects of dopamine D1 receptor agonists in rats trained to discriminate dihydrexidine.

Gleason SD, Witkin JM. Gleason SD, et al. Psychopharmacology (Berl). 2006 May;186(1):25-31. doi: 10.1007/s00213-006-0342-2. Epub 2006 Mar 31. Psychopharmacology (Berl). 2006. PMID: 16575553

3

Effects of dopamine D1 receptor full agonists in rats trained to discriminate SKF 38393.

Gleason SD, Witkin JM. Gleason SD, et al. Behav Pharmacol. 2004 Feb;15(1):85-9. doi: 10.1097/00008877-200402000-00010. Behav Pharmacol. 2004. PMID: 15075630

4

In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder.

Barth V, Need AB, Tzavara ET, Giros B, Overshiner C, Gleason SD, Wade M, Johansson AM, Perry K, Nomikos GG, Witkin JM. Barth V, et al. Among authors: gleason sd. J Pharmacol Exp Ther. 2013 Feb;344(2):501-10. doi: 10.1124/jpet.112.198895. Epub 2012 Nov 29. J Pharmacol Exp Ther. 2013. PMID: 23197772

5

Anxiolytic-like effects through a GLUK5 kainate receptor mechanism.

Alt A, Weiss B, Ornstein PL, Gleason SD, Bleakman D, Stratford RE Jr, Witkin JM. Alt A, et al. Among authors: gleason sd. Neuropharmacology. 2007 Jun;52(7):1482-7. doi: 10.1016/j.neuropharm.2007.02.005. Epub 2007 Mar 2. Neuropharmacology. 2007. PMID: 17418283

6

A parametric analysis of punishment frequency as a determinant of the response to chlordiazepoxide in the Vogel conflict test in rats.

Gleason SD, Witkin JM. Gleason SD, et al. Pharmacol Biochem Behav. 2007 Aug-Sep;87(3):380-5. doi: 10.1016/j.pbb.2007.05.011. Epub 2007 May 24. Pharmacol Biochem Behav. 2007. PMID: 17583779

7

Electroencephalographic, cognitive, and neurochemical effects of LY3130481 (CERC-611), a selective antagonist of TARP-γ8-associated AMPA receptors.

Witkin JM, Li J, Gilmour G, Mitchell SN, Carter G, Gleason SD, Seidel WF, Eastwood BJ, McCarthy A, Porter WJ, Reel J, Gardinier KM, Kato AS, Wafford KA. Witkin JM, et al. Among authors: gleason sd. Neuropharmacology. 2017 Nov;126:257-270. doi: 10.1016/j.neuropharm.2017.07.028. Epub 2017 Jul 28. Neuropharmacology. 2017. PMID: 28757050

8

Effects of 5-HT₇ receptor antagonists on behaviors of mice that detect drugs used in the treatment of anxiety, depression, or schizophrenia.

Maxwell J, Gleason SD, Falcone J, Svensson K, Balcer OM, Li X, Witkin JM. Maxwell J, et al. Among authors: gleason sd. Behav Brain Res. 2019 Feb 1;359:467-473. doi: 10.1016/j.bbr.2018.11.019. Epub 2018 Nov 22. Behav Brain Res. 2019. PMID: 30471311

9

Evaluation of 5-HT₇ receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice.

Balcer OM, Seager MA, Gleason SD, Li X, Rasmussen K, Maxwell JK, Nomikos G, Degroot A, Witkin JM. Balcer OM, et al. Among authors: gleason sd. Behav Brain Res. 2019 Mar 15;360:270-278. doi: 10.1016/j.bbr.2018.12.019. Epub 2018 Dec 10. Behav Brain Res. 2019. PMID: 30543903

10

A medium throughput rodent model of relapse from addiction with behavioral and pharmacological specificity.

Eiler WJA 2nd, Gleason SD, Smith JL, Witkin JM. Eiler WJA 2nd, et al. Among authors: gleason sd. Pharmacol Biochem Behav. 2019 Aug;183:72-79. doi: 10.1016/j.pbb.2019.06.005. Epub 2019 Jun 14. Pharmacol Biochem Behav. 2019. PMID: 31202811 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters